PTP
SRPT icon

Platform Technology Partners’s Sarepta Therapeutics SRPT Stock Holding History

Platform Technology Partners’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,262
Closed -$275K – 243
2024
Q4 		$275K Sell
2,262
-200
-8% -$24.5K 0.08% 178
2024
Q3 		$307K Buy
2,462
+325
+15% +$44.9K 0.1% 175
2024
Q2 		$338K Buy
+2,137
New +$275K 0.12% 154
2023
Q4 		$272K Sell
2,137
-988
-32% -$94.8K 0.11% 169
2023
Q3 		$379K Sell
3,125
-150
-5% -$17K 0.18% 122
2023
Q2 		$355K Buy
3,275
+12
+0.4% +$1.55K 0.17% 133
2023
Q1 		$450K Buy
3,263
+208
+7% +$27K 0.22% 108
2022
Q4 		$396K Hold
3,055
– – 0.2% 118
2022
Q3 		$338K Sell
3,055
-353
-10% -$35.6K 0.19% 121
2022
Q2 		$255K Buy
3,408
+3
+0.1% +$221 0.14% 152
2022
Q1 		$266K Hold
3,405
– – 0.13% 156
2021
Q4 		$307K Hold
3,405
– – 0.13% 161
2021
Q3 		$315K Sell
3,405
-920
-21% -$70.9K 0.14% 161
2021
Q2 		$336K Buy
+4,325
New +$328K 0.14% 171
2020
Q4 		$731K Sell
4,290
-250
-6% -$37K 0.36% 78
2020
Q3 		$638K Buy
4,540
+730
+19% +$111K 0.39% 72
2020
Q2 		$611K Sell
3,810
-845
-18% -$115K 0.43% 67
2020
Q1 		$455K Sell
4,655
-3,380
-42% -$386K 0.41% 67
2019
Q4 		$1.04M Buy
+8,035
New +$811K 0.78% 31

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Platform Technology Partners's SRPT Position: Q1 2025 in Review

Platform Technology Partners sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 2,262 shares — an estimated $275K sold.

Platform Technology Partners first reported a position in SRPT in Q4 2019 and held it in 19 quarters. The position peaked at $1.04M in Q4 2019. 431 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • Platform Technology Partners reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Platform Technology Partners sold 2,262 Sarepta Therapeutics shares in Q1 2025, an estimated $275K.
  • Platform Technology Partners first reported a position in Sarepta Therapeutics in Q4 2019 and held it in 19 quarters.
  • Platform Technology Partners's Sarepta Therapeutics position peaked at $1.04M in Q4 2019.
  • 431 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Platform Technology Partners's 13F filing for Q1 2025, filed 1 May 2025.